Drug-Resistant Pulmonary Tuberculosis
Current Standings in Indonesia
Keywords:
Mycobacterium tuberculosis (MTb), drug resistance, risk factors, potential treatment, natural compounds
Abstract
Tuberculosis (TB) caused by the pathogenic bacteria Mycobacterium tuberculosis (MTb) still remains a highly prevalent disease, particularly in low and middle-income countries. Due to the bacteria’s atypical cell wall structure, ability to form granuloma, and capacity to switch between replicating and non-replicating states in the host lung parenchyma, the fundamental treatment of patients diagnosed with TB involves a 6-month long daily drug administration. With Indonesia ranking among the nations with the highest TB burden worldwide, there has been an alarming increase of drug-resistant MTb (DR-MTb) strains all over the country in recent years. However, there are currently limited studies available that highlight MTb resistance profiles across different regions within Indonesia. The major risk factors contributing to the emergence and spread of TB in Indonesia include health conditions, environmental conditions, and socioeconomic status. Furthermore, natural compounds and drug repurposing can be employed to combat the further spread of DR-MTb strains across the country, especially in rural regions.
Downloads
Download data is not yet available.
References
Abraham, A. O., Nasiru, A. U., Abdulazeez, A. K., Seun, O. O., & Ogonna, D. W. (2020). Mechanism of Drug Resistance in Mycobacterium tuberculosis. Am. J. Biomed. Sci. Res, 5, 378-383. doi: 10.34297/AJBSR.2020.07.001181
Aderita, N. I., Murti, B., Suryani, N. (2016). Risk Factors Affecting Multi-Drug Resistant Tuberculosis in Surakarta and Ngawi, Indonesia. Journal of Epidemiology and Public Health, 1(2), 86-99. doi: jepublichealth.2016.01.02.02
Alisjahbana, B., van Crevel, R., Sahiratmadja, E., den Heijer, M., Maya, A., Istriana, E., … & van der Meer, J. W. (2006). Diabetes Mellitus is Strongly Associated with Tuberculosis in Indonesia. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 10(6), 696–700.
Amere, G. A., Nayak, P., Salindri, A. D., Narayan, K. M. V., & Magee, M. J. (2018). Contribution of Smoking to Tuberculosis Incidence and Mortality in High-Tuberculosis-Burden Countries. American Journal of Epidemiology, 187(9), 1846–1855. doi: 10.1093/aje/kwy081
Amin, A. G., Goude, R., Shi, L., Zhang, J., Chatterjee, D., & Parish, T. (2008). embA is an Essential Arabinosyltransferase in Mycobacterium tuberculosis. Microbiology, 154(1), 240. doi: 10.1099/mic.0.2007/012153-0
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2014). A Silent Mutation in mabA Confers Isoniazid Resistance on Mycobacterium tuberculosis. Molecular Microbiology, 91(3), 538-547. doi: 10.1111/mmi.12476
André, E., Goeminne, L., Cabibbe, A., Beckert, P., Mukadi, B. K., Mathys, V., ... & Cambau, E. (2017). Consensus Numbering System For The Rifampicin Resistance-Associated rpoB Gene Mutations In Pathogenic Mycobacteria. Clinical Microbiology and Infection, 23(3), 167-172. doi: 10.1016/j.cmi.2016.09.006
Ang, M. L. T., Siti, Z. Z. R., Shui, G., Dianišková, P., Madacki, J., Lin, W., ... & Alonso, S. (2014). An ethA-ethR-Deficient Mycobacterium bovis BCG Mutant Displays Increased Adherence to Mammalian Cells and Greater Persistence In Vivo, Which Correlate with Altered Mycolic Acid Composition. Infection and Immunity, 82(5), 1850-1859. doi: 10.1128/IAI.01332-13
Ang, M. L., Zainul Rahim, S. Z., de Sessions, P. F., Lin, W., Koh, V., Pethe, K., ... & Alonso, S. (2017). EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide. Frontiers in Microbiology, 8, 710. doi: 10.3389/fmicb.2017.00710
Anwar, M. S. T. (2015). Association between Smoking and Drinking Alcohol with Prevalence of Tuberculosis in Patients with Diabetes Mellitus in Jakarta Primary Health Centre. (Bachelor’s thesis). Universitas Indonesia.
Apsari, P., Afrida, B., Ronaldi, M., & Supadma, I. (2020). Correlation between Tuberculosis and Nutritional Status among Children in North Lombok, West Nusa Tenggara, Indonesia. The Proceedings of the 1st Seminar The Emerging of Novel Corona Virus, NCov 2020, 11-12 February 2020, Bali, Indonesia. doi: 10.4108/eai.11-2-2020.2302038
Aristiana, C. D., & Wartono, M. (2018). Faktor-Faktor yang Mempengaruhi Kejadian Multi Drug Resistance Tuberkulosis (MDR-TB). Jurnal Biomedika dan Kesehatan, 1(1), 65-74. doi: 10.18051/jbiomedkes.2018.v1.65-74
Asres, A., Jerene, D., & Deressa, W. (2016). Tuberculosis Treatment Outcomes of Six and Eight Month Treatment Regimens in Districts of Southwestern Ethiopia: A Comparative Cross-Sectional Study. BMC Infectious Diseases, 16(1), 1-8. doi: 10.1186/s12879-016-1917-0
Astuti, S. M., Sakinah, M. A., Andayani, R. B., & Risch, A. (2011). Determination of Saponin Compound from Anredera cordifolia (Ten) Steenis Plant (binahong) to Potential Treatment for Several Diseases. Journal of Agricultural Science, 3(4), 224. doi: 10.5539/jas.v3n4p224
Awad, S. F., Critchley, J. A., & Abu-Raddad, L. J. (2022). Impact of Diabetes Mellitus on Tuberculosis Epidemiology in Indonesia: A Mathematical Modeling Analysis. Tuberculosis, 134, 102164. doi:10.1016/j.tube.2022.102164.
Baker, M. A., Harries, A. D., Jeon, C. Y., Hart, J. E., Kapur, A., Lönnroth, K., … & Murray, M. B. (2011). The Impact of Diabetes on Tuberculosis Treatment Outcomes: A Systematic Review. BMC Medicine, 9, 81. doi: 10.1186/1741-7015-9-81
Bam, T. S., Aditama, T. Y., Chiang, C. Y., Rubaeah, R., & Suhaemi, A. (2015). Smoking Cessation and Smokefree Environments for Tuberculosis Patients in Indonesia - A Cohort Study. BMC Public Health, 15, 604. doi: 10.1186/s12889-015-1972-2
Bandiara, R., Indrasari, A., Dewi Rengganis, A., Sukesi, L., Afiatin, A., & Santoso, P. (2022). Risk Factors of Latent Tuberculosis among Chronic Kidney Disease with Routine Haemodialysis Patients. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 27, 100302. doi: 10.1016/j.jctube.2022.100302
Blumberg, H. M., Burman, W. J., Chaisson, R. E., Daley, C. L., Etkind, S. C., Friedman, L. N., … & American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167(4), 603–662. doi: 10.1164/rccm.167.4.603
Boisson, M., Jacobs, M., Grégoire, N., Gobin, P., Marchand, S., Couet, W., & Mimoz, O. (2014). Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients. Antimicrobial Agents And Chemotherapy, 58(12), 7331-7339. doi: 10.1128/AAC.03510-14
Brown, F., González, J., & Monan, M. (2019). Pharmacognostic, Physicochemical and Phytochemical Analysis of Two Cultivars from Hibiscus sabdariffa L. in Cuba. Open Access Library Journal, 6(12), 1-8. doi: 10.4236/oalib.1105894
Burhan, E., Karyana, M., Karuniawati, A., Kusmiati, T., Wibisono, B. H., Handayani, D., ... & Siddiqui, S. (2022). Characteristics of Drug-sensitive and Drug-resistant Tuberculosis Cases Among Adults at Tuberculosis Referral Hospitals in Indonesia. The American Journal of Tropical Medicine and Hygiene, 107(5), 984-991. doi: 10.4269/ajtmh.22-0142
Burusie, A., Enquesilassie, F., Addissie, A., Dessalegn, B., & Lamaro, T. (2020). Effect of Smoking on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-analysis. PLoS ONE, 15(9), e0239333. doi: 10.1371/journal.pone.0239333
Cahyani, T. D., Rahayu S. R., Jamilatun, F., & Merzistya, A. N. A. (2021). Multi-Drug Resistant Tuberculosis in Semarang City. Public Health Perspectives Journal, 6(2), 148-158.
Campbell, J. R., Al-Jahdali, H., Bah, B., Belo, M., Cook, V. J., Long, R., … & Menzies, D. (2021). Safety and Efficacy of Rifampin or Isoniazid among People with Mycobacterium tuberculosis Infection and Living with Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 73(9), e3545–e3554. doi: 10.1093/cid/ciaa1169
Cegielski, J. P., & McMurray, D. N. (2004). The Relationship between Malnutrition and Tuberculosis: Evidence from Studies in Humans and Experimental Animals. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 8(3), 286–298.
Chaidir, L., Sengstake, S., de Beer, J., Krismawati, H., Lestari, F. D., Ayawaila, S., … & Alisjahbana, B. (2015). Mycobacterium tuberculosis Genotypic Drug Resistance Patterns and Clustering in Jayapura, Papua, Indonesia. The International Journal of Tuberculosis and Lung Disease, 19(4), 428-433. doi: 10.5588/ijtld.14.0350
Chaidir, L., Ruesen, C., Dutilh, B. E., Ganiem, A. R., Andryani, A., Apriani, L., ... & Alisjahbana, B. (2019). Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Drug Resistance in Indonesia. Journal of Global Antimicrobial Resistance, 16, 170-177. doi: 10.1016/j.jgar.2018.08.018
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., … & Zumla, A. (2021). Global Tuberculosis Report 2020 – Reflections on the Global TB Burden, Treatment and Prevention Efforts. International Journal of Infectious Diseases, 113(1), S7-S12. doi: 10.1016/j.ijid.2021.02.107
Choerunisa, T. F., Lismayanti, L., Rostini, T., Bayusantika, R., & Parwati, I. (2021). Comparison of Line Probe Assay (LPA) and Mycobacterium Growth Indicator Tubes (MGIT) Assay for Second-line TB Drug Susceptibility Testing. The Indonesian Biomedical Journal, 13(3), 256-60. doi: 10.18585/inabj.v13i3.1521
Cohen, G., & Hörl, W. H. (2012). Immune Dysfunction in Uremia—An Update. Toxins, 4(11), 962–990. doi: 10.3390/toxins4110962
Cohen, K. A., Stott, K. E., Munsamy, V., Manson, A. L., Earl, A. M., & Pym, A. S. (2020). Evidence for Expanding the Role of Streptomycin in the Management of Drug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 64(9), e00860-20. doi: 10.1128/aac.00860-20
Cruz-Knight, W., & Blake-Gumbs, L. (2013). Tuberculosis: An Overview. Primary Care, 40(3), 743–756. doi: 10.1016/j.pop.2013.06.003
Cuevas-Córdoba, B., Cuellar-Sánchez, A., Pasissi-Crivelli, A., Santana-Álvarez, C. A., Hernández-Illezcas, J., & Zenteno-Cuevas, R. (2013). rrs and rpsL Mutations in Streptomycin-resistant Isolates of Mycobacterium tuberculosis from Mexico. Journal of Microbiology, Immunology and Infection, 46(1), 30-34. doi: 10.1016/j.jmii.2012.08.020
Delogu, G., Sali, M., & Fadda, G. (2013). The Biology of Mycobacterium tuberculosis Infection. Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013070. doi: 10.4084/MJHID.2013.070
Dewi, A. P. (2020). Prevalence and Characteristic of Drug-resistant Tuberculosis Patients in South Halmahera District, Eastern Indonesia. European Respiratory Journal, 56(64), 505. doi: 10.1183/13993003.congress-2020.505
Dey, D., Ray, R., & Hazra, B. (2015a). Antimicrobial Activity of Pomegranate Fruit Constituents against Drug-resistant Mycobacterium tuberculosis and β-Lactamase Producing Klebsiella pneumoniae. Pharmaceutical Biology, 53(10), 1474-1480. doi: 10.3109/13880209.2014.986687
Dey, D., Ray, R., & Hazra, B. (2015b). Antibacterial and Antitubercular Activity of Selected Plant Products against Multi-drug Resistant Clinical Isolates. Res, 1021, 1014-21.
Djide, N. J. N., Djide, M. N., Amir, M. N., & Sartini, S. (2019). Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), 5(2), 117-123. doi: 10.22487/j24428744.2019.v5.i2.12946
Dutta, N., & Karakousis, P. (2015). Can the Duration of Tuberculosis Treatment be Shortened with Higher Dosages of Rifampicin?. Frontiers In Microbiology, 6. doi: 10.3389/fmicb.2015.01117
Faisal, E. G., Amirah, S., Maulana, S., Komariah, M., & Platini, H. (2022). Role of Curcumin as a Potential Immunomodulator to Adjunct Tuberculosis Treatment in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(F), 326-331. doi: 10.3889/oamjms.2022.8981
Fatimatuzzuhro, Sundari, A. S., & Indriati, D. W. (2020). The Prevalence of Pulmonary Tuberculosis Among Newly Diagnosed HIV/AIDS Individuals Admitted in Gresik, Indonesia. Malaysian Journal of Medicine and Health Sciences, 16, 4-8.
Fauziyah, P. N., Sukandar, E. Y., & Ayuningtyas, D. K. (2017). Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-drug Resistant Mycobacterium Tuberculosis Isolates. Scientia Pharmaceutica, 85(1), 14. doi: 10.3390/scipharm85010014
Fogel, N. (2015). Tuberculosis: A Disease Without Boundaries. Tuberculosis, 95(5), 527-531. doi: 10.1016/j.tube.2015.05.017
Fuady, A., Houweling, T. A. J., Mansyur, M., & Richardus, J. H. (2018). Catastrophic Total Costs in Tuberculosis-affected Households and their Determinants since Indonesia's Implementation of Universal Health Coverage. Infectious Diseases of Poverty, 7(1), 3. doi: 10.1186/s40249-017-0382-3
Gadkowski, L. B., & Stout, J. E. (2008). Cavitary Pulmonary Disease. Clinical Microbiology Reviews, 21(2), 305–333.doi: 10.1128/CMR.00060-07
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., … & Raviglione, M. (2015). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, 46(6), 1563-1576. doi: 10.1183/13993003.01245-2015
Ghaesani, N. M., Effendy, R. R., & Wulandari, D. A. (2021). Radiological Findings Of Pulmonary Tuberculosis in Children at dr. Hasan Sadikin General Hospital Bandung 2018–2019. Althea Medical Journal, 8(4), 198-203. doi: 10.15850/amj.v8n4.2338
Gikalo, M. B., Nosova, E. Y., Krylova, L. Y., & Moroz, A. M. (2012). The Role of Eis Mutations in the Development of Kanamycin Resistance in Mycobacterium tuberculosis Isolates from the Moscow Region. Journal of Antimicrobial Chemotherapy, 67(9), 2107–2109. doi: 10.1093/jac/dks178
Goletti, D., Lindestam Arlehamn, C. S., Scriba, T. J., Anthony, R., Cirillo, D. M., Alonzi, T., Denkinger, C. M., & Cobelens, F. (2018). Can We Predict Tuberculosis Cure? What Tools Are Available?. European Respiratory Journal, 52(5). doi: 10.1183/13993003.01089-2018
Gopal, P., Grüber, G., Dartois, V., & Dick, T. (2019). Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide. Trends in Pharmacological Sciences, 40(12), 930-940. doi: 10.1016/j.tips.2019.10.005
Gumilang, R. R., Indriati, D. W., Diyantoro, D., & Sundari, A. S. (2022). The Occurrence of Tuberculosis Infection among Newly HIV Diagnosed Patient in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(A), 893–896. doi: 10.3889/oamjms.2022.9529
Gupta, V. K., Kumar, M. M., Bisht, D., & Kaushik, A. (2017). Plants in our Combating Strategies against Mycobacterium tuberculosis: Progress Made and Obstacles Met. Pharmaceutical Biology, 55(1), 1536-1544. doi: 10.1080/13880209.2017.1309440
Gurvitz, A. (2009). The Essential Mycobacterial Genes, fabG1 and fabG4, Encode 3-Oxoacyl-Thioester Reductases that are Functional in Yeast Mitochondrial Fatty Acid Synthase Type 2. Molecular Genetics and Genomics: MGG, 282(4), 407–416. doi: 10.1007/s00438-009-0474-2
Harmayani, E., Anal, A. K., Wichienchot, S., Bhat, R., Gardjito, M., Santoso, U., & Payyappallimana, U. (2019). Healthy Food Traditions of Asia: Exploratory Case Studies from Indonesia, Thailand, Malaysia, and Nepal. Journal of Ethnic Foods, 6(1), 1-18. doi: 10.1186/s42779-019-0002-x
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995). Missense Mutations in the Catalase-Peroxidase Gene, katG, are Associated with Isoniazid Resistance in Mycobacterium tuberculosis. Molecular Microbiology, 15(2), 235–245. doi: 10.1111/j.1365-2958.1995.tb02238.x
Icksan, A. G., Napitupulu, M. R. S., Nawas, M. A., & Nurwidya, F. (2018). Chest X-ray Findings Comparison between Multi-drug-resistant Tuberculosis and Drug-sensitive Tuberculosis. Journal of Natural Science, Biology, and Medicine, 9(1), 42–46. doi: 10.4103/jnsbm.JNSBM_79_17
Isa, M., Nurrasyidah, I., Nikmah, E. H., Rahmawaty, D., Assagaf, A., Haryati, H., & Kusumawardhani, E. (2022). Nutritional Status of Hospitalized Tuberculosis Patients in South Kalimantan: A Cross-sectional Study. Mutiara Medika: Jurnal Kedokteran Dan Kesehatan, 22(2). doi: 10.18196/mmjkk.v22i2.15021
Jnawali, H. N., & Ryoo, S. (2013). First- and Second-line Drugs and Drug Resistance. Tuberculosis-current Issues in Diagnosis and Management, 20, 163-80. doi: 10.5772/54960
Kadri, A., Machmud, R., Putra, A., & Indrapriyatna, A. S. (2022). Factors Associated of Multidrug-resistance Tuberculosis among Minangkabau Ethnicity in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(B), 1736–1739. doi: 10.3889/oamjms.2022.8980
Kant, S., Gupta, H., & Ahluwalia, S. (2015). Significance of Nutrition in Pulmonary Tuberculosis. Critical Reviews in Food Science and Nutrition, 55(7), 955–963. doi: 10.1080/10408398.2012.679500
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., … & Bekker, L. G. (2003). Mycobacterium tuberculosis Growth at the Cavity Surface: A Microenvironment with Failed Immunity. Infection and Immunity, 71(12), 7099–7108. doi: 10.1128/IAI.71.12.7099-7108.2003
Karyadi, E., Schultink, W., Nelwan, R. H., Gross, R., Amin, Z., Dolmans, W. M., … West, C. E. (2000). Poor Micronutrient Status of Active Pulmonary Tuberculosis Patients in Indonesia. The Journal of Nutrition, 130(12), 2953-2958. doi: 10.1093/jn/130.12.2953
Khan, S. R., Manialawy, Y., & Siraki, A. G. (2019). Isoniazid and Host Immune System Interactions: A Proposal for a Novel Comprehensive Mode of Action. British Journal of Pharmacology, 176(24), 4599–4608. doi: 10.1111/bph.14867
Kim, M. J., Wainwright, H. C., Locketz, M., Bekker, L. G., Walther, G. B., Dittrich, C., … & Russell, D. G. (2010). Caseation of Human Tuberculosis Granulomas Correlates with Elevated Host Lipid Metabolism. EMBO Molecular Medicine, 2(7), 258–274. doi: 10.1002/emmm.201000079
Kim, S. Y., Kim, D. H., Moon, S. M., Song, J. Y., Huh, H. J., Lee, N. Y., ... & Jhun, B. W. (2021). Association between 16S rRNA Gene Mutations and Susceptibility to Amikacin in Mycobacterium avium Complex and Mycobacterium abscessus Clinical Isolates. Scientific Reports, 11(1), 1-8. doi: 10.1038/s41598-021-85721-5
Kocaadam, B., & Şanlier, N. (2017). Curcumin, an Active Component of Turmeric (Curcuma longa), and its Effects on Health. Critical Reviews in Food Science and Nutrition, 57(13), 2889-2895. doi: 10.1080/10408398.2015.1077195
Kridaningsih, T. N., Widiyanti, M., Adiningsih, S., Hutapea, H. M., Fitriana, E., & Natalia, E. I. (2021). Profile of HIV/AIDS Patients Coinfected with Tuberculosis in Bumi Wonorejo Health Centre and Santo Rafael Clinic Nabire, Papua. Jurnal Kedokteran Brawijaya, 31(4), 10. doi: 10.21776/ub.jkb.2021.031.04.10
Krock, B. L., Skuli, N., & Simon, M. C. (2011). Hypoxia-Induced Angiogenesis: Good and Evil. Genes & Cancer, 2(12), 1117–1133. doi: 10.1177/1947601911423654
Kurnia, A. D., Melizza, N., & Masruroh, N. (2020). Factors Related to the Low Nutritional Status among Tuberculosis Patients. Jurnal Keperawatan Padjadjaran, 8(1). doi: 10.24198/jkp.v8i1.1294
Lakshmanan, D., Werngren, J., Jose, L., Suja, K. P., Nair, M. S., Varma, R. L., … & Kumar, R. A. (2011). Ethyl p-methoxycinnamate Isolated from a Traditional Anti-tuberculosis Medicinal Herb Inhibits Drug Resistant Strains of Mycobacterium tuberculosis In Vitro. Fitoterapia, 82(5), 757-761. doi: 10.1016/j.fitote.2011.03.006
Lee, N., & Nguyen, H. (2021). Ethambutol. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK559050/
Lena, A. P., Eddy Purwoto, B., & Maya, P. G. (2019). Aktifitas Antibakteri Ekstrak Etanol Kaliks Bunga Rosella Merah (Hibiscus Sabdariffa L.) terhadap Mycobacterium tuberculosis. Journal Archives Pharmacia, 1(1), 5-8.
Liberato, I. R., de Albuquerque, M.deF., Campelo, A. R., & de Melo, H. R. (2004). Characteristics of Pulmonary Tuberculosis in HIV Seropositive and Seronegative Patients in a Northeastern Region of Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 37(1), 46–50. doi: 10.1590/s0037-86822004000100012
Lönnroth, K., Roglic, G., & Harries, A. D. (2014). Improving Tuberculosis Prevention and Care Through Addressing the Global Diabetes Epidemic: From Evidence to Policy and Practice. The Lancet Diabetes & Endocrinology, 2(9), 730–739. doi: 10.1016/S2213-8587(14)70109-3
Maison, D. P. (2022). Tuberculosis pathophysiology and anti-VEGF intervention. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 27, 100300. doi: 10.1016/j.jctube.2022.100300
Majdawati, A., Icksan, A. G., & Lolong, D. (2019). Comparison of Chest X-ray Lesion Characteristics of Multidrug-resistant Tuberculosis and Non-tuberculous Mycobacterial Infection. Polish Journal of Radiology, 84, e162–e170. doi: 10.5114/pjr.2019.84515
Makalew, L. (2010). Faktor Risiko Alkoholisme terhadap Penderita TB Paru BTA Positif di Puskesmas Kawangkoan Kabupaten Minahasa. JIK, 5(1).
Maladan, Y., Krismawati, H., Wahyuni, T., Tanjung, R., Awaludin, K., Audah, K. A., & Parikesit, A. A. (2021). The Whole-Genome Sequencing in Predicting Mycobacterium tuberculosis Drug Susceptibility And Resistance in Papua, Indonesia. BMC Genomics, 22(1), 1-11. doi: 10.1186/s12864-021-08139-3
Ma’rufi, I., Ali, K., Sedemen, I. A., Purwanto, P., & Khoiri, A. (2019). Channa striata (ikan gabus) Extract and the Acceleration of Tuberculosis Treatment: A True Experimental Study. Interdisciplinary Perspectives on Infectious Diseases, 2019, 1-7. doi: 10.1155/2019/8013959
Ma'rufi, I., Ali, K., Jati, S. K., Sukmawati, A., Ardiansyah, K., & Ningtyias, F. W. (2020). Improvement of Nutritional Status among Tuberculosis Patients by Channa striata Supplementation: A True Experimental Study in Indonesia. BioMed Research International, 2020, 7491702. doi: 10.1155/2020/7491702
Marbun, R. I. (2022). Korelasi Keadaan Rumah dengan Kejadian Penyakit TBC Paru. Jurnal Riset Rumpun Ilmu Kedokteran, 1(2), 31-37. doi:10.55606/jurrike.v1i2.410
Massi, M. N., Wahyuni, S., Halik, H., Anita, Yusuf, I., Leong, F. J., … & Phyu, S. (2011). Drug Resistance among Tuberculosis Patients Attending Diagnostic and Treatment Centres in Makassar, Indonesia. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 15(4), 489–495. doi: 10.5588/ijtld.09.0730
Mehta, P., Bothiraja, C., Kadam, S., & Pawar, A. (2018). Potential of Dry Powder Inhalers for Tuberculosis Therapy: Facts, Fidelity and Future. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup3), S791-S806. doi: 10.1080/21691401.2018.1513938
Mitchison, D. A. (1985). The Action of Antituberculosis Drugs in Short-Course Chemotherapy. Tubercle, 66(3), 219-225. doi: 10.1016/0041-3879(85)90040-6
Modongo, C., Sobota, R. S., Kesenogile, B., Ncube, R., Sirugo, G., Williams, S. M., & Zetola, N. M. (2014). Successful MDR-TB Treatment Regimens Including Amikacin are Associated with High Rates of Hearing Loss. BMC Infectious Diseases, 14(1), 1-9. doi: 10.1186/1471-2334-14-542
Molina, P. E., Happel, K. I., Zhang, P., Kolls, J. K., & Nelson, S. (2010). Focus on: Alcohol and the Immune System. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 33(1-2), 97–108.
Mourya, N. M. N., & Mourya, R. M. R. (2017). Multidrug-resistant Tuberculosis (MDR-TB). International Journal of Indigenous Herbs and Drugs, 2(4), 17-23.
Mucugi, N. M. (2017). Molecular Targets and Mechanisms of Action of Pyrazinamide in Mycobacterium tuberculosis (Doctoral dissertation, COPAS, JKUAT).
Musfirah, M., Nurfita, D., & Rangkuti, A. F. (2022). Analysis of Healthy Housing and TB Prevalence in Yogyakarta City. Jurnal Kesehatan Masyarakat, 17(3), 405-414. doi:10.15294/kemas.v17i3.28692
Musser, J. M. (1995). Antimicrobial Agent Resistance in Mycobacteria: Molecular Genetic Insights. Clinical Microbiology Reviews, 8(4), 496-514. doi: 10.1128/CMR.8.4.496
Nawas, A. 2010. Penatalaksanaan TB MDR dan Strategi DOTS Plus. Jurnal Tuberkulosis Indonesia, 7(10), 1-7.
Nijenbandring de Boer, R., Baptista de Oliveira e Souza Filho, J., Cobelens, F., de Paula Ramalho, D., Campino Miranda, P. F., de Logo, K., … & Kritski, A. (2014). Delayed Culture Conversion due to Cigarette Smoking in Active Pulmonary Tuberculosis Patients. Tuberculosis, 94(1), 87–91. doi:10.1016/j.tube.2013.10.005
Nindrea, R. D., Sari, N. P., Harahap, W. A., Haryono, S. J., Kusnanto, H., Dwiprahasto, I., … & Aryandono, T. (2020). Survey Data of Multidrug-resistant Tuberculosis, Tuberculosis Patients Characteristics and Stress Resilience during COVID-19 Pandemic in West Sumatera Province, Indonesia. Data in Brief, 32, 106293. doi: 10.1016/j.dib.2020.106293
Noviyani, A., Nopsopon, T., & Pongpirul, K. (2021). Variation of Tuberculosis Prevalence Across Diagnostic Approaches and Geographical Areas of Indonesia. PLoS ONE, 16(10), e0258809. doi: 10.1371/journal.pone.0258809
Nurhayati-Wolff, H. (2022). Share of the Population Aged 15 Years and Above Who Smoked in Indonesia from 2015 to 2021. Statista.com. Retrieved from https://www.statista.com/statistics/955144/indonesia-smoking-rate/
Nusrath Unissa, A., & Hanna, L. (2017). Molecular Mechanisms of Action, Resistance, Detection to the First-line Anti Tuberculosis Drugs: Rifampicin and Pyrazinamide in the Post Whole Genome Sequencing Era. Tuberculosis, 105, 96-107. doi: 10.1016/j.tube.2017.04.008
O’Connor, C., & Brady, M. F. (2022). Isoniazid - LiverTox - NCBI Bookshelf. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK548754/
Oxlade, O., & Murray, M. (2012). Tuberculosis and Poverty: Why are the Poor at Greater Risk in India? PLoS ONE, 7(11), e47533. doi: 10.1371/journal.pone.0047533
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., … & Raviglione, M. (2016). Tuberculosis. Nature Reviews Disease Primers, 2(1). doi: 10.1038/nrdp.2016.76
Pakadang, S. R., Hilaria, M., Dewi, S. T. R., & Sinala, S. (2021). MIC and MKC Analysis of Herbal Medicine in Indonesia against Mycobacterium tuberculosis. Pharmacognosy Journal, 13(5). doi: 10.5530/pj.2021.13.137
Palomino, J. C., & Martin, A. (2014). Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics, 3(3), 317-340. doi: 10.3390/antibiotics3030317
Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffé, M., & Duncan, K. (2007). Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG. Journal of Bacteriology, 189(10), 3721–3728. doi: 10.1128/JB.01740-06
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012). Tuberculosis and HIV Co-infection. PLoS Pathogens, 8(2), e1002464. doi: 10.1371/journal.ppat.1002464
Phelan, J., Coll, F., McNerney, R., Ascher, D. B., Pires, D. E., Furnham, N., ... & Clark, T. G. (2016). Mycobacterium tuberculosis Whole Genome Sequencing and Protein Structure Modelling Provides Insights into Anti-Tuberculosis Drug Resistance. BMC Medicine, 14(1), 1-13. doi: 10.1186/s12916-016-0575-9
Pitaloka, D. A. E., & Sukandar, E. Y. (2018). Synergistic Study on n-Hexane Extract of Anredera cordifolia (Ten.)v Steenis (binahong) Leaves Combined with Antituberculosis Drugs against Drug-sensitive and Drug-resistant of Mycobacterium tuberculosis. Journal of Applied Pharmaceutical Science, 8(5), 134-138. doi: 10.7324/JAPS.2018.8518
Plinke, C., Cox, H. S., Zarkua, N., Karimovich, H. A., Braker, K., Diel, R., ... & Niemann, S. (2010). embCAB sequence Variation Among Ethambutol-resistant Mycobacterium tuberculosis Isolates without embB 306 Mutation. Journal of Antimicrobial Chemotherapy, 65(7), 1359-1367. doi: 10.1093/jac/dkq120
Pontororing, G. J., Kenangalem, E., Lolong, D. B., Waramori, G., Sandjaja, Tjitra, E., … & Ralph, A. P. (2010). The Burden and Treatment of HIV in Tuberculosis Patients in Papua Province, Indonesia: A Prospective Observational Study. BMC Infectious Diseases, 10, 362. doi: 10.1186/1471-2334-10-362
Pradana, R. F., Nawawi, Y., & Satoto, B. (2018). Chest X-ray Evaluation of Cavitary Lesions among Pulmonary MDR-TB Patients in Kariadi Hospital, Semarang, Indonesia. EJournal Kedokteran Indonesia, 6(2). doi: 10.23886/ejki.6.8468
Putranto, M., Wongkar, M. C., & Sugeng, C. (2018). Profil Pasien Tuberkulosis Paru dengan Penyakit Ginjal Kronik yang Dirawat di RSUP Prof. dr. R. D. Kandou Manado Periode Oktober 2017 – Oktober 2018. E-CliniC, 6(2). doi: 10.35790/ecl.6.2.2018.22113
Ramirez, M. S., & Tolmasky, M. E. (2017). Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules, 22(12), 2267. doi: 10.3390/molecules22122267
Rauf, A., Tahar, N., & Resnia, R. (2019). Aktivitas Penghambatan Fraksi Daun Delima (Punica granatum L.) terhadap Bakteri Mycobacterium tuberculosis. Jurnal Kesehatan, 70-76. doi: 10.24252/kesehatan.v0i0.18044
Rawat, R., Whitty, A., & Tonge, P. J. (2003). The Isoniazid-NAD Adduct is a Slow, Tight-Binding Inhibitor of InhA, the Mycobacterium tuberculosis Enoyl Reductase: Adduct Affinity and Drug Resistance. Proceedings of the National Academy of Sciences, 100(24), 13881-13886. doi: 10.1073/pnas.2235848100
Rehm, J., Baliunas, D., Borges, G. L., Graham, K., Irving, H., Kehoe, T., … & Taylor, B. (2010). The Relation between Different Dimensions of Alcohol Consumption and Burden of Disease: An Overview. Addiction, 105(5), 817–843. doi: 10.1111/j.1360-0443.2010.02899.x
Restrepo, B. I. (2016). Diabetes and Tuberculosis. Microbiology Spectrum, 4(6), 595-606. doi: 10.1128/microbiolspec.TNMI7-0023-2016
Ritonga, I. (2020). Malnutrition Risk Factors In TBC: A Case Study in Medan, Indonesia. Jurnal Aisyah: Jurnal Ilmu Kesehatan, 5(1), 107-111. doi: 10.30604/jika.v5i1.539
Ruiz, P., Rodriguez-Cano, F., Zerolo, F. J., & Casal, M. (2003). Streptomycin as Second-line Chemotherapy for Tuberculosis. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia, 16(2), 188-194.
Russell D. G. (2001). Mycobacterium tuberculosis: Here Today, and Here Tomorrow. Nature Reviews Molecular Cell Biology, 2(8), 569–577. doi: 10.1038/35085034
Ruzangi, J., Iwagami, M., Smeeth, L., Mangtani, P., & Nitsch, D. (2020). The Association between Chronic Kidney Disease and Tuberculosis: A Comparative Cohort Study in England. BMC Nephrology, 21(1), 420. doi: 10.1186/s12882-020-02065-4
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008). Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, And Rifampin. Antimicrobial Agents and Chemotherapy, 52(6), 2027–2034. doi: 10.1128/AAC.01486-07
Safi, H., Lingaraju, S., Amin, A., Kim, S., Jones, M., Holmes, M., … & Alland, D. (2013). Evolution of High-Level Ethambutol-resistant Tuberculosis Through Interacting Mutations in Decaprenylphosphoryl-β-D-arabinose Biosynthetic and Utilization Pathway Genes. Nature Genetics, 45(10), 1190–1197. doi: 10.1038/ng.2743
Safitri, E. A., Siagian, P., Sinaga, B. Y., & Eyanoer, P. C. (2022). Vitamin C Supplementation Improves Pulmonary Tuberculosis Patients' Sputum Conversion during Intensive Phase Category I Treatment in Medan. Respiratory Science, 2(2), 72-77. doi: 10.36497/respirsci.v2i2.30
Sahiratmadja, E., Mega, G. S., Andriyoko, B., & Parwati, I. (2020). Performance of Xpert® MTB/RIF in Detecting Multidrug-Resistance Tuberculosis in West Java, Indonesia. Majalah Kedokteran Bandung, 52(2), 99-106. doi: 10.15395/mkb.v52n2.1966
Santucci, P., Aylan, B., Botella, L., Bernard, E. M., Bussi, C., Pellegrino, E., ... & Gutierrez, M. G. (2022). Visualizing Pyrazinamide Action by Live Single-cell Imaging of Phagosome Acidification and Mycobacterium tuberculosis pH Homeostasis. mBio, 13(2), e00117-22. doi: 10.1101/2021.12.20.473466
Sanz-García, F., Anoz-Carbonell, E., Pérez-Herrán, E., Martín, C., Lucía, A., Rodrigues, L., & Aínsa, J. A. (2019). Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles. Frontiers in Microbiology, 10, 46. doi: 10.3389/fmicb.2019.00046
Saraswati, L. (2014). Prevalens Diabetes Mellitus dan Tuberkulosis Paru. KEMAS: Jurnal Kesehatan Masyarakat, 9(2), 206-2010. doi:10.15294/kemas.v9i2.2850
Sari, D. K., Marpaung, A. P., Siagian, P., & Arrasyid, N. K. (2019). Vitamin A Supplementation in Pulmonary Tuberculosis Patients on Acceleration of Sputum Conversion in Medan City. Open Access Macedonian Journal of Medical Sciences, 7(20), 3505-3508. doi: 10.3889/oamjms.2019.688
Sartini, S., Djide, M. N., Gemini Alam, A. A., & Djide, N. J. N. (2020). In Vitro Antioxidant and Anti-Mycobacterial Activities of Roselle (Hibiscus sabdariffa L.) Calyx Extract against Clinical Isolate of Multidrug Resistant Mycobacterium tuberculosis. Systematic Reviews in Pharmacy, 11(5), 36-39.
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015). Multidrug-resistant Tuberculosis and Extensively Drug-resistant Tuberculosis. Cold Spring Harbor Perspectives in Medicine, 5(9), a017863. doi: 10.1101/cshperspect.a017863
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., … & Zhang, Y. (2011). Pyrazinamide Inhibits Trans-translation in Mycobacterium tuberculosis. Science, 333(6049), 1630-1632. doi: 10.1126/science.1208813
Sianturi, R. (2014). Analisis Faktor yang Berhubungan dengan Kekambuhan TB Paru (Studi Kasus di BKPM Semarang Tahun 2013). Unnes Journal of Public Health, 3(1). doi: 10.15294/ujph.v3i1.3157
Simet, S. M., & Sisson, J. H. (2015). Alcohol's Effects on Lung Health and Immunity. Alcohol Research: Current Reviews, 37(2), 199–208.
Sinaga, B. Y., Siregar, Y., Amin, M., & Sarumpaet, S. (2018). Effect of Smoking and Alcohol Consumption on Pulmonary Tuberculosis among Batak Ethnic Population in Medan, Indonesia. IOP Conference Series: Earth and Environmental Science, 125, 012139. doi:10.1088/1755-1315/125/1/012139
Siregar, R. J., Yusuf, S. F., & Fernaldy, D. (2022). The Relationship between Physical Conditions of the House and the Incidence of Tuberculosis. International Journal of Public Health Excellence (IJPHE), 1(1), 01-05. doi:10.55299/ijphe.v1i1.2
Siroka, A., Law, I., Macinko, J., Floyd, K., Banda, R. P., Hoa, N. B., … & Ponce, N. A. (2016). The Effect of Household Poverty on Tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 20(12), 1603–1608. doi: 10.5588/ijtld.16.0386
Slayden, R. A., & Barry, C. E. (2002). The Role of KasA and KasB in the Biosynthesis of Meromycolic Acids and Isoniazid Resistance in Mycobacterium tuberculosis. Tuberculosis, 82(4-5), 149–160. doi: 10.1054/tube.2002.0333
Soeroto, A. Y., Lestari, B. W., Santoso, P., Chaidir, L., Andriyoko, B., Alisjahbana, B., ... & Hill, P. C. (2019). Evaluation of Xpert MTB-RIF Guided Diagnosis and Treatment of Rifampicin-resistant Tuberculosis in Indonesia: A Retrospective Cohort Study. PLoS ONE, 14(2), e0213017. doi: 10.1371/journal.pone.0213017
Soeroto, A. Y., Pratiwi, C., Santoso, P., & Lestari, B. W. (2021). Factors Affecting Outcome of Longer Regimen Multidrug-resistant Tuberculosis Treatment in West Java Indonesia: A Retrospective Cohort Study. PLoS ONE, 16(2), e0246284. doi: 10.1371/journal.pone.0246284
Sotgiu, G., Centis, R., D'ambrosio, L., & Migliori, G. B. (2015). Tuberculosis Treatment and Drug Regimens. Cold Spring Harbor Perspectives in Medicine, 5(5), a017822. doi: 10.1101/cshperspect.a017822
Sowajassatakul, A., Prammananan, T., Chaiprasert, A., & Phunpruch, S. (2014). Molecular Characterization of Amikacin, Kanamycin and Capreomycin Resistance in M/XDR-TB Strains Isolated in Thailand. BMC Microbiology, 14(1), 1-7. doi: 10.1186/1471-2180-14-165
Sreevatsan, S., Pan, X., Stockbauer, K. E., Williams, D. L., Kreiswirth, B. N., & Musser, J. M. (1996). Characterization of rpsL and rrs Mutations in Streptomycin-resistant Mycobacterium tuberculosis Isolates from Diverse Geographic Localities. Antimicrobial Agents and Chemotherapy, 40(4), 1024-1026. doi: 10.1128/aac.40.4.1024
Stek, C., Allwood, B., Walker, N. F., Wilkinson, R. J., Lynen, L., & Meintjes, G. (2018). The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Frontiers in Microbiology, 9, 2603. doi: 10.3389/fmicb.2018.02603
Sturkenboom, M. G., Simbar, N., Akkerman, O. W., Ghimire, S., Bolhuis, M. S., & Alffenaar, J. W. C. (2018). Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment. Clinical Infectious Diseases, 67(suppl_3), S303-S307. doi: 10.1093/cid/ciy613
Sultana, Z. Z., Hoque, F. U., Beyene, J., Islam, M. A. U., Khan, M. H. R., Ahmed, S., … & Hossain, A. (2021). HIV Infection and Multidrug Resistant Tuberculosis: A Systematic Review and Meta-analysis. BMC Infectious Diseases, 21(51). doi: 10.1186/s12879-020-05749-2
Sun, Q., Li, X., Perez, L. M., Shi, W., Zhang, Y., & Sacchettini, J. C. (2020). The Molecular Basis of Pyrazinamide Activity on Mycobacterium tuberculosis PanD. Nature Communications, 11(1), 1-7. doi: 10.1038/s41467-019-14238-3
Syamsuddin, S., Askar, M., Lestari, I. D., Sahani, W., & Ahmad, H. (2020). The Relationship between Housing Condition and Pulmonary Tuberculosis Disease in Baraya Village, Bontoala Makassar, Indonesia. Indian Journal of Forensic Medicine & Toxicology, 14(4), 3517-3523. doi: 10.37506/ijfmt.v14i4.12172
Tam, K. K., Leung, K. S., Siu, G. K., Chang, K. C., Wong, S. S., Ho, P. L., … & Yam, W. C. (2019). Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. Journal of Clinical Microbiology, 57(8), e00145-19. doi: 10.1128/JCM.00145-19
Tang, R. A., Schiffman, J., Cruz, R. A., & Corsi, G. (2014). Ethambutol: Friend or foe?. Expert Review of Ophthalmology, 9(2), 59-61. doi: 10.1586/17469899.2014.898564
Tania, T., Sudarmono, P., Kusumawati, R. L., Rukmana, A., Pratama, W. A., Regmi, S. M., … & Faksri, K. (2020). Whole-Genome Sequencing Analysis of Multidrug-resistant Mycobacterium tuberculosis from Java, Indonesia. Journal of Medical Microbiology, 69(7), 1013-1019. doi: 10.1099/jmm.0.001221
Taslim, I. (2016). Association of Bacterial Load Degree with Cavity in TB Patient in Persahabatan Hospital. (Bachelor’s thesis). Universitas Indonesia.
Tiberi, S., Utjesanovic, N., Galvin, J., Centis, R., D’Ambrosio, L., van den Boom, M., … & Migliori, G. B. (2022). Drug Resistant TB – Latest Developments in Epidemiology, Diagnostics and Management. International Journal of Infectious Diseases, 124, S20-S25. doi: 10.1016/j.ijid.2022.03.026
Tjekyan, S., Novita, E., & Ismah, Z. (2018). Multidrug-resistant Tuberculosis (MDR-TB): Incidence Rate in Palembang City, South Sumatra, Indonesia. Jurnal Biotek Medisiana Indonesia, 7(1), 19-25. doi: 10.22435/jbmi.v7i1.1566
Tobing, K. L., Nainggolan, O., Rachmawati, F., Manalu, H. S., Sagala, R. D., & Kusrini, I. (2021). The Relationship between Malnutrition and Tuberculosis (TB) at the Age Group More Than 18 Years Old in Indonesia (Analysis of the Basic Health Research 2018). International Journal of Innovation, Creativity and Change, 332-348. doi: 10.53333/ijicc2013/15941
Tseng, S. T., Tai, C. H., Li, C. R., Lin, C. F., & Shi, Z. Y. (2015). The Mutations of katG and inhA Genes of Isoniazid-resistant Mycobacterium tuberculosis Isolates in Taiwan. Journal of Microbiology, Immunology and Infection, 48(3), 249-255. doi: 10.1016/j.jmii.2013.08.018
Umar, M. I., Asmawi, M. Z., Sadikun, A., Majid, A. M. S. A., Al-Suede, F. S. R., Hassan, L. E. A., ... & Ahamed, M. B. K. (2014). Ethyl-p-methoxycinnamate Isolated from Kaempferia galanga Inhibits Inflammation by Suppressing Interleukin-1, Tumor Necrosis Factor-α, and Angiogenesis by Blocking Endothelial Functions. Clinics, 69, 134-144. doi: 10.6061/clinics/2014(02)10
Umar, F. F., Husain, D. R., Hatta, M. M., Natzir, R. R., Sjahril, R. S., Dwiyanti, R. R., Junita, A. R., & Primaguna, M. R. (2020). Molecular Characterisation of Mutations Associated with Resistance to First- and Second-line Drugs among Indonesian Patients with Tuberculosis. Journal of Taibah University Medical Sciences, 15(1), 54-58. doi: 10.1016/j.jtumed.2019.12.003
Urbanowski, M. E., Ordonez, A. A., Ruiz-Bedoya, C. A., Jain, S. K., & Bishai, W. R. (2020). Cavitary Tuberculosis: The Gateway of Disease Transmission. The Lancet Infectious Diseases, 20(6), e117–e128. doi: 10.1016/S1473-3099(20)30148-1
Vera, Y., Sinaga, B. Y., Ardinata, D., & Siregar, Y. (2018). The Effect of pncA Gene Mutation of Mycobacterium tuberculosis to Rransaminase and Uric Acid Serum in MDR-TB Patients. Jurnal Respirologi Indonesia, 38(3), 150-157. doi: 10.36497/jri.v38i3.4
Wahyudi, A. S., Raufuddin, & Suarilah, I. (2018). The Relationship between Healthy Housing Conditions and Pulmonary Tuberculosis. Proceedings of the 9th International Nursing Conference. doi:10.5220/0008330506570663
Wang, F., Shen, H., Guan, M., Wang, Y., Feng, Y., Weng, X., ... & Zhang, W. (2011). High-resolution Melting Facilitates Mutation Screening of rpsL Gene Associated with Streptomycin Resistance in Mycobacterium tuberculosis. Microbiological Research, 166(2), 121-128. doi: 10.1016/j.micres.2010.02.001
Waters, M., & Tadi, P. (2020). Streptomycin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555886/
Wei, M., Zhao, Y., Qian, Z., Yang, B., Xi, J., Wei, J., & Tang, B. (2020). Pneumonia Caused by Mycobacterium tuberculosis. Microbes and Infection, 22(6-7), 278-284. doi: 10.1016/j.micinf.2020.05.020
Widiastuti, E. N., Subronto, Y. W., & Promono, D. (2017). Determinan Kejadian Multi-drug Resistant Tuberculosis di RSUP dr. Sardjito. Berita Kedokteran Masyarakat, 33(7), 325. doi:10.22146/bkm.18290
Windiyaningsih, C., & Badaruddin, H. (2021). Factors Influenced of Drug-Resistant Tuberculosis and Non-Drug-resistant Tuberculosis Patients in Pulmonary Hospital dr. M. Goenawan Partowidigdo, Bogor District. Tarumanagara Medical Journal, 3(2), 238-248. doi:10.24912/tmj.v4i1.13714
Wiwing, V., Widysanto, A., & Lugito, N. P. H. (2015). Mycobacterium tuberculosis Resistance Pattern Against First-line Drugs in Patients from Urban Area. International Journal of Mycobacteriology, 4(4), 302-305. doi: 10.1016/j.ijmyco.2015.08.002
World Health Organization. (2019). Global Tuberculosis Report 2019. Geneva: WHO.
World Health Organization. (2021). Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association with Drug Resistance. Geneva: WHO
World Health Organization. (2022). Global Tuberculosis Report 2022. Geneva: WHO.
Xi, Y., Zhang, W., Qiao, R. J., & Tang, J. (2022). Risk Factors for Multidrug-resistant Tuberculosis: A Worldwide Systematic Review and Meta-analysis. PLoS ONE, 17(6), e2070003. doi: 10.1371/journal.pone.0270003
Yao, F., Huang, Y., Wang, Y., & He, X. (2018). Anti-inflammatory Diarylheptanoids and Phenolics from the Rhizomes of Kencur (Kaempferia galanga L.). Industrial Crops and Products, 125, 454-461. doi: 10.1016/j.indcrop.2018.09.026
Zhang, Y., Shi, W., Zhang, W., & Mitchison, D. (2014). Mechanisms of Pyrazinamide Action and Resistance. Microbiology Spectrum, 2(4), 2-4. doi: 10.1128/microbiolspec.MGM2-0023-2013
Zhang, Q., An, X., Liu, H., Wang, S., Xiao, T., & Liu, H. (2019). Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin due to RNA Polymerase H451D/Y/R Mutations from Computational Perspective. Frontiers in Chemistry, 7, 819. doi: 10.3389/fchem.2019.00819
Zhang, Z., Wang, W., Wang, Y., Xue, Z., Li, S., & Pang, Y. (2022). Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China. Infection and Drug Resistance, 15, 2287. doi: 10.2147/idr.s357887
Zaunbrecher, M. A., Sikes Jr, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009). Overexpression of the Chromosomally Encoded Aminoglycoside Acetyltransferase Eis Confers Kanamycin Resistance in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 106(47), 20004-20009. doi: 10.1073/pnas.0907925106
Zhu, C., Liu, Y., Hu, L., Yang, M., & He, Z. G. (2018). Molecular Mechanism of the Synergistic Activity of Ethambutol and Isoniazid against Mycobacterium tuberculosis. Journal of Biological Chemistry, 293(43), 16741-16750. doi: 10.1074/jbc.RA118.002693
Aderita, N. I., Murti, B., Suryani, N. (2016). Risk Factors Affecting Multi-Drug Resistant Tuberculosis in Surakarta and Ngawi, Indonesia. Journal of Epidemiology and Public Health, 1(2), 86-99. doi: jepublichealth.2016.01.02.02
Alisjahbana, B., van Crevel, R., Sahiratmadja, E., den Heijer, M., Maya, A., Istriana, E., … & van der Meer, J. W. (2006). Diabetes Mellitus is Strongly Associated with Tuberculosis in Indonesia. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 10(6), 696–700.
Amere, G. A., Nayak, P., Salindri, A. D., Narayan, K. M. V., & Magee, M. J. (2018). Contribution of Smoking to Tuberculosis Incidence and Mortality in High-Tuberculosis-Burden Countries. American Journal of Epidemiology, 187(9), 1846–1855. doi: 10.1093/aje/kwy081
Amin, A. G., Goude, R., Shi, L., Zhang, J., Chatterjee, D., & Parish, T. (2008). embA is an Essential Arabinosyltransferase in Mycobacterium tuberculosis. Microbiology, 154(1), 240. doi: 10.1099/mic.0.2007/012153-0
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2014). A Silent Mutation in mabA Confers Isoniazid Resistance on Mycobacterium tuberculosis. Molecular Microbiology, 91(3), 538-547. doi: 10.1111/mmi.12476
André, E., Goeminne, L., Cabibbe, A., Beckert, P., Mukadi, B. K., Mathys, V., ... & Cambau, E. (2017). Consensus Numbering System For The Rifampicin Resistance-Associated rpoB Gene Mutations In Pathogenic Mycobacteria. Clinical Microbiology and Infection, 23(3), 167-172. doi: 10.1016/j.cmi.2016.09.006
Ang, M. L. T., Siti, Z. Z. R., Shui, G., Dianišková, P., Madacki, J., Lin, W., ... & Alonso, S. (2014). An ethA-ethR-Deficient Mycobacterium bovis BCG Mutant Displays Increased Adherence to Mammalian Cells and Greater Persistence In Vivo, Which Correlate with Altered Mycolic Acid Composition. Infection and Immunity, 82(5), 1850-1859. doi: 10.1128/IAI.01332-13
Ang, M. L., Zainul Rahim, S. Z., de Sessions, P. F., Lin, W., Koh, V., Pethe, K., ... & Alonso, S. (2017). EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide. Frontiers in Microbiology, 8, 710. doi: 10.3389/fmicb.2017.00710
Anwar, M. S. T. (2015). Association between Smoking and Drinking Alcohol with Prevalence of Tuberculosis in Patients with Diabetes Mellitus in Jakarta Primary Health Centre. (Bachelor’s thesis). Universitas Indonesia.
Apsari, P., Afrida, B., Ronaldi, M., & Supadma, I. (2020). Correlation between Tuberculosis and Nutritional Status among Children in North Lombok, West Nusa Tenggara, Indonesia. The Proceedings of the 1st Seminar The Emerging of Novel Corona Virus, NCov 2020, 11-12 February 2020, Bali, Indonesia. doi: 10.4108/eai.11-2-2020.2302038
Aristiana, C. D., & Wartono, M. (2018). Faktor-Faktor yang Mempengaruhi Kejadian Multi Drug Resistance Tuberkulosis (MDR-TB). Jurnal Biomedika dan Kesehatan, 1(1), 65-74. doi: 10.18051/jbiomedkes.2018.v1.65-74
Asres, A., Jerene, D., & Deressa, W. (2016). Tuberculosis Treatment Outcomes of Six and Eight Month Treatment Regimens in Districts of Southwestern Ethiopia: A Comparative Cross-Sectional Study. BMC Infectious Diseases, 16(1), 1-8. doi: 10.1186/s12879-016-1917-0
Astuti, S. M., Sakinah, M. A., Andayani, R. B., & Risch, A. (2011). Determination of Saponin Compound from Anredera cordifolia (Ten) Steenis Plant (binahong) to Potential Treatment for Several Diseases. Journal of Agricultural Science, 3(4), 224. doi: 10.5539/jas.v3n4p224
Awad, S. F., Critchley, J. A., & Abu-Raddad, L. J. (2022). Impact of Diabetes Mellitus on Tuberculosis Epidemiology in Indonesia: A Mathematical Modeling Analysis. Tuberculosis, 134, 102164. doi:10.1016/j.tube.2022.102164.
Baker, M. A., Harries, A. D., Jeon, C. Y., Hart, J. E., Kapur, A., Lönnroth, K., … & Murray, M. B. (2011). The Impact of Diabetes on Tuberculosis Treatment Outcomes: A Systematic Review. BMC Medicine, 9, 81. doi: 10.1186/1741-7015-9-81
Bam, T. S., Aditama, T. Y., Chiang, C. Y., Rubaeah, R., & Suhaemi, A. (2015). Smoking Cessation and Smokefree Environments for Tuberculosis Patients in Indonesia - A Cohort Study. BMC Public Health, 15, 604. doi: 10.1186/s12889-015-1972-2
Bandiara, R., Indrasari, A., Dewi Rengganis, A., Sukesi, L., Afiatin, A., & Santoso, P. (2022). Risk Factors of Latent Tuberculosis among Chronic Kidney Disease with Routine Haemodialysis Patients. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 27, 100302. doi: 10.1016/j.jctube.2022.100302
Blumberg, H. M., Burman, W. J., Chaisson, R. E., Daley, C. L., Etkind, S. C., Friedman, L. N., … & American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167(4), 603–662. doi: 10.1164/rccm.167.4.603
Boisson, M., Jacobs, M., Grégoire, N., Gobin, P., Marchand, S., Couet, W., & Mimoz, O. (2014). Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients. Antimicrobial Agents And Chemotherapy, 58(12), 7331-7339. doi: 10.1128/AAC.03510-14
Brown, F., González, J., & Monan, M. (2019). Pharmacognostic, Physicochemical and Phytochemical Analysis of Two Cultivars from Hibiscus sabdariffa L. in Cuba. Open Access Library Journal, 6(12), 1-8. doi: 10.4236/oalib.1105894
Burhan, E., Karyana, M., Karuniawati, A., Kusmiati, T., Wibisono, B. H., Handayani, D., ... & Siddiqui, S. (2022). Characteristics of Drug-sensitive and Drug-resistant Tuberculosis Cases Among Adults at Tuberculosis Referral Hospitals in Indonesia. The American Journal of Tropical Medicine and Hygiene, 107(5), 984-991. doi: 10.4269/ajtmh.22-0142
Burusie, A., Enquesilassie, F., Addissie, A., Dessalegn, B., & Lamaro, T. (2020). Effect of Smoking on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-analysis. PLoS ONE, 15(9), e0239333. doi: 10.1371/journal.pone.0239333
Cahyani, T. D., Rahayu S. R., Jamilatun, F., & Merzistya, A. N. A. (2021). Multi-Drug Resistant Tuberculosis in Semarang City. Public Health Perspectives Journal, 6(2), 148-158.
Campbell, J. R., Al-Jahdali, H., Bah, B., Belo, M., Cook, V. J., Long, R., … & Menzies, D. (2021). Safety and Efficacy of Rifampin or Isoniazid among People with Mycobacterium tuberculosis Infection and Living with Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 73(9), e3545–e3554. doi: 10.1093/cid/ciaa1169
Cegielski, J. P., & McMurray, D. N. (2004). The Relationship between Malnutrition and Tuberculosis: Evidence from Studies in Humans and Experimental Animals. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 8(3), 286–298.
Chaidir, L., Sengstake, S., de Beer, J., Krismawati, H., Lestari, F. D., Ayawaila, S., … & Alisjahbana, B. (2015). Mycobacterium tuberculosis Genotypic Drug Resistance Patterns and Clustering in Jayapura, Papua, Indonesia. The International Journal of Tuberculosis and Lung Disease, 19(4), 428-433. doi: 10.5588/ijtld.14.0350
Chaidir, L., Ruesen, C., Dutilh, B. E., Ganiem, A. R., Andryani, A., Apriani, L., ... & Alisjahbana, B. (2019). Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Drug Resistance in Indonesia. Journal of Global Antimicrobial Resistance, 16, 170-177. doi: 10.1016/j.jgar.2018.08.018
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., … & Zumla, A. (2021). Global Tuberculosis Report 2020 – Reflections on the Global TB Burden, Treatment and Prevention Efforts. International Journal of Infectious Diseases, 113(1), S7-S12. doi: 10.1016/j.ijid.2021.02.107
Choerunisa, T. F., Lismayanti, L., Rostini, T., Bayusantika, R., & Parwati, I. (2021). Comparison of Line Probe Assay (LPA) and Mycobacterium Growth Indicator Tubes (MGIT) Assay for Second-line TB Drug Susceptibility Testing. The Indonesian Biomedical Journal, 13(3), 256-60. doi: 10.18585/inabj.v13i3.1521
Cohen, G., & Hörl, W. H. (2012). Immune Dysfunction in Uremia—An Update. Toxins, 4(11), 962–990. doi: 10.3390/toxins4110962
Cohen, K. A., Stott, K. E., Munsamy, V., Manson, A. L., Earl, A. M., & Pym, A. S. (2020). Evidence for Expanding the Role of Streptomycin in the Management of Drug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 64(9), e00860-20. doi: 10.1128/aac.00860-20
Cruz-Knight, W., & Blake-Gumbs, L. (2013). Tuberculosis: An Overview. Primary Care, 40(3), 743–756. doi: 10.1016/j.pop.2013.06.003
Cuevas-Córdoba, B., Cuellar-Sánchez, A., Pasissi-Crivelli, A., Santana-Álvarez, C. A., Hernández-Illezcas, J., & Zenteno-Cuevas, R. (2013). rrs and rpsL Mutations in Streptomycin-resistant Isolates of Mycobacterium tuberculosis from Mexico. Journal of Microbiology, Immunology and Infection, 46(1), 30-34. doi: 10.1016/j.jmii.2012.08.020
Delogu, G., Sali, M., & Fadda, G. (2013). The Biology of Mycobacterium tuberculosis Infection. Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013070. doi: 10.4084/MJHID.2013.070
Dewi, A. P. (2020). Prevalence and Characteristic of Drug-resistant Tuberculosis Patients in South Halmahera District, Eastern Indonesia. European Respiratory Journal, 56(64), 505. doi: 10.1183/13993003.congress-2020.505
Dey, D., Ray, R., & Hazra, B. (2015a). Antimicrobial Activity of Pomegranate Fruit Constituents against Drug-resistant Mycobacterium tuberculosis and β-Lactamase Producing Klebsiella pneumoniae. Pharmaceutical Biology, 53(10), 1474-1480. doi: 10.3109/13880209.2014.986687
Dey, D., Ray, R., & Hazra, B. (2015b). Antibacterial and Antitubercular Activity of Selected Plant Products against Multi-drug Resistant Clinical Isolates. Res, 1021, 1014-21.
Djide, N. J. N., Djide, M. N., Amir, M. N., & Sartini, S. (2019). Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), 5(2), 117-123. doi: 10.22487/j24428744.2019.v5.i2.12946
Dutta, N., & Karakousis, P. (2015). Can the Duration of Tuberculosis Treatment be Shortened with Higher Dosages of Rifampicin?. Frontiers In Microbiology, 6. doi: 10.3389/fmicb.2015.01117
Faisal, E. G., Amirah, S., Maulana, S., Komariah, M., & Platini, H. (2022). Role of Curcumin as a Potential Immunomodulator to Adjunct Tuberculosis Treatment in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(F), 326-331. doi: 10.3889/oamjms.2022.8981
Fatimatuzzuhro, Sundari, A. S., & Indriati, D. W. (2020). The Prevalence of Pulmonary Tuberculosis Among Newly Diagnosed HIV/AIDS Individuals Admitted in Gresik, Indonesia. Malaysian Journal of Medicine and Health Sciences, 16, 4-8.
Fauziyah, P. N., Sukandar, E. Y., & Ayuningtyas, D. K. (2017). Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-drug Resistant Mycobacterium Tuberculosis Isolates. Scientia Pharmaceutica, 85(1), 14. doi: 10.3390/scipharm85010014
Fogel, N. (2015). Tuberculosis: A Disease Without Boundaries. Tuberculosis, 95(5), 527-531. doi: 10.1016/j.tube.2015.05.017
Fuady, A., Houweling, T. A. J., Mansyur, M., & Richardus, J. H. (2018). Catastrophic Total Costs in Tuberculosis-affected Households and their Determinants since Indonesia's Implementation of Universal Health Coverage. Infectious Diseases of Poverty, 7(1), 3. doi: 10.1186/s40249-017-0382-3
Gadkowski, L. B., & Stout, J. E. (2008). Cavitary Pulmonary Disease. Clinical Microbiology Reviews, 21(2), 305–333.doi: 10.1128/CMR.00060-07
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., … & Raviglione, M. (2015). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, 46(6), 1563-1576. doi: 10.1183/13993003.01245-2015
Ghaesani, N. M., Effendy, R. R., & Wulandari, D. A. (2021). Radiological Findings Of Pulmonary Tuberculosis in Children at dr. Hasan Sadikin General Hospital Bandung 2018–2019. Althea Medical Journal, 8(4), 198-203. doi: 10.15850/amj.v8n4.2338
Gikalo, M. B., Nosova, E. Y., Krylova, L. Y., & Moroz, A. M. (2012). The Role of Eis Mutations in the Development of Kanamycin Resistance in Mycobacterium tuberculosis Isolates from the Moscow Region. Journal of Antimicrobial Chemotherapy, 67(9), 2107–2109. doi: 10.1093/jac/dks178
Goletti, D., Lindestam Arlehamn, C. S., Scriba, T. J., Anthony, R., Cirillo, D. M., Alonzi, T., Denkinger, C. M., & Cobelens, F. (2018). Can We Predict Tuberculosis Cure? What Tools Are Available?. European Respiratory Journal, 52(5). doi: 10.1183/13993003.01089-2018
Gopal, P., Grüber, G., Dartois, V., & Dick, T. (2019). Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide. Trends in Pharmacological Sciences, 40(12), 930-940. doi: 10.1016/j.tips.2019.10.005
Gumilang, R. R., Indriati, D. W., Diyantoro, D., & Sundari, A. S. (2022). The Occurrence of Tuberculosis Infection among Newly HIV Diagnosed Patient in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(A), 893–896. doi: 10.3889/oamjms.2022.9529
Gupta, V. K., Kumar, M. M., Bisht, D., & Kaushik, A. (2017). Plants in our Combating Strategies against Mycobacterium tuberculosis: Progress Made and Obstacles Met. Pharmaceutical Biology, 55(1), 1536-1544. doi: 10.1080/13880209.2017.1309440
Gurvitz, A. (2009). The Essential Mycobacterial Genes, fabG1 and fabG4, Encode 3-Oxoacyl-Thioester Reductases that are Functional in Yeast Mitochondrial Fatty Acid Synthase Type 2. Molecular Genetics and Genomics: MGG, 282(4), 407–416. doi: 10.1007/s00438-009-0474-2
Harmayani, E., Anal, A. K., Wichienchot, S., Bhat, R., Gardjito, M., Santoso, U., & Payyappallimana, U. (2019). Healthy Food Traditions of Asia: Exploratory Case Studies from Indonesia, Thailand, Malaysia, and Nepal. Journal of Ethnic Foods, 6(1), 1-18. doi: 10.1186/s42779-019-0002-x
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995). Missense Mutations in the Catalase-Peroxidase Gene, katG, are Associated with Isoniazid Resistance in Mycobacterium tuberculosis. Molecular Microbiology, 15(2), 235–245. doi: 10.1111/j.1365-2958.1995.tb02238.x
Icksan, A. G., Napitupulu, M. R. S., Nawas, M. A., & Nurwidya, F. (2018). Chest X-ray Findings Comparison between Multi-drug-resistant Tuberculosis and Drug-sensitive Tuberculosis. Journal of Natural Science, Biology, and Medicine, 9(1), 42–46. doi: 10.4103/jnsbm.JNSBM_79_17
Isa, M., Nurrasyidah, I., Nikmah, E. H., Rahmawaty, D., Assagaf, A., Haryati, H., & Kusumawardhani, E. (2022). Nutritional Status of Hospitalized Tuberculosis Patients in South Kalimantan: A Cross-sectional Study. Mutiara Medika: Jurnal Kedokteran Dan Kesehatan, 22(2). doi: 10.18196/mmjkk.v22i2.15021
Jnawali, H. N., & Ryoo, S. (2013). First- and Second-line Drugs and Drug Resistance. Tuberculosis-current Issues in Diagnosis and Management, 20, 163-80. doi: 10.5772/54960
Kadri, A., Machmud, R., Putra, A., & Indrapriyatna, A. S. (2022). Factors Associated of Multidrug-resistance Tuberculosis among Minangkabau Ethnicity in Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(B), 1736–1739. doi: 10.3889/oamjms.2022.8980
Kant, S., Gupta, H., & Ahluwalia, S. (2015). Significance of Nutrition in Pulmonary Tuberculosis. Critical Reviews in Food Science and Nutrition, 55(7), 955–963. doi: 10.1080/10408398.2012.679500
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., … & Bekker, L. G. (2003). Mycobacterium tuberculosis Growth at the Cavity Surface: A Microenvironment with Failed Immunity. Infection and Immunity, 71(12), 7099–7108. doi: 10.1128/IAI.71.12.7099-7108.2003
Karyadi, E., Schultink, W., Nelwan, R. H., Gross, R., Amin, Z., Dolmans, W. M., … West, C. E. (2000). Poor Micronutrient Status of Active Pulmonary Tuberculosis Patients in Indonesia. The Journal of Nutrition, 130(12), 2953-2958. doi: 10.1093/jn/130.12.2953
Khan, S. R., Manialawy, Y., & Siraki, A. G. (2019). Isoniazid and Host Immune System Interactions: A Proposal for a Novel Comprehensive Mode of Action. British Journal of Pharmacology, 176(24), 4599–4608. doi: 10.1111/bph.14867
Kim, M. J., Wainwright, H. C., Locketz, M., Bekker, L. G., Walther, G. B., Dittrich, C., … & Russell, D. G. (2010). Caseation of Human Tuberculosis Granulomas Correlates with Elevated Host Lipid Metabolism. EMBO Molecular Medicine, 2(7), 258–274. doi: 10.1002/emmm.201000079
Kim, S. Y., Kim, D. H., Moon, S. M., Song, J. Y., Huh, H. J., Lee, N. Y., ... & Jhun, B. W. (2021). Association between 16S rRNA Gene Mutations and Susceptibility to Amikacin in Mycobacterium avium Complex and Mycobacterium abscessus Clinical Isolates. Scientific Reports, 11(1), 1-8. doi: 10.1038/s41598-021-85721-5
Kocaadam, B., & Şanlier, N. (2017). Curcumin, an Active Component of Turmeric (Curcuma longa), and its Effects on Health. Critical Reviews in Food Science and Nutrition, 57(13), 2889-2895. doi: 10.1080/10408398.2015.1077195
Kridaningsih, T. N., Widiyanti, M., Adiningsih, S., Hutapea, H. M., Fitriana, E., & Natalia, E. I. (2021). Profile of HIV/AIDS Patients Coinfected with Tuberculosis in Bumi Wonorejo Health Centre and Santo Rafael Clinic Nabire, Papua. Jurnal Kedokteran Brawijaya, 31(4), 10. doi: 10.21776/ub.jkb.2021.031.04.10
Krock, B. L., Skuli, N., & Simon, M. C. (2011). Hypoxia-Induced Angiogenesis: Good and Evil. Genes & Cancer, 2(12), 1117–1133. doi: 10.1177/1947601911423654
Kurnia, A. D., Melizza, N., & Masruroh, N. (2020). Factors Related to the Low Nutritional Status among Tuberculosis Patients. Jurnal Keperawatan Padjadjaran, 8(1). doi: 10.24198/jkp.v8i1.1294
Lakshmanan, D., Werngren, J., Jose, L., Suja, K. P., Nair, M. S., Varma, R. L., … & Kumar, R. A. (2011). Ethyl p-methoxycinnamate Isolated from a Traditional Anti-tuberculosis Medicinal Herb Inhibits Drug Resistant Strains of Mycobacterium tuberculosis In Vitro. Fitoterapia, 82(5), 757-761. doi: 10.1016/j.fitote.2011.03.006
Lee, N., & Nguyen, H. (2021). Ethambutol. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK559050/
Lena, A. P., Eddy Purwoto, B., & Maya, P. G. (2019). Aktifitas Antibakteri Ekstrak Etanol Kaliks Bunga Rosella Merah (Hibiscus Sabdariffa L.) terhadap Mycobacterium tuberculosis. Journal Archives Pharmacia, 1(1), 5-8.
Liberato, I. R., de Albuquerque, M.deF., Campelo, A. R., & de Melo, H. R. (2004). Characteristics of Pulmonary Tuberculosis in HIV Seropositive and Seronegative Patients in a Northeastern Region of Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 37(1), 46–50. doi: 10.1590/s0037-86822004000100012
Lönnroth, K., Roglic, G., & Harries, A. D. (2014). Improving Tuberculosis Prevention and Care Through Addressing the Global Diabetes Epidemic: From Evidence to Policy and Practice. The Lancet Diabetes & Endocrinology, 2(9), 730–739. doi: 10.1016/S2213-8587(14)70109-3
Maison, D. P. (2022). Tuberculosis pathophysiology and anti-VEGF intervention. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 27, 100300. doi: 10.1016/j.jctube.2022.100300
Majdawati, A., Icksan, A. G., & Lolong, D. (2019). Comparison of Chest X-ray Lesion Characteristics of Multidrug-resistant Tuberculosis and Non-tuberculous Mycobacterial Infection. Polish Journal of Radiology, 84, e162–e170. doi: 10.5114/pjr.2019.84515
Makalew, L. (2010). Faktor Risiko Alkoholisme terhadap Penderita TB Paru BTA Positif di Puskesmas Kawangkoan Kabupaten Minahasa. JIK, 5(1).
Maladan, Y., Krismawati, H., Wahyuni, T., Tanjung, R., Awaludin, K., Audah, K. A., & Parikesit, A. A. (2021). The Whole-Genome Sequencing in Predicting Mycobacterium tuberculosis Drug Susceptibility And Resistance in Papua, Indonesia. BMC Genomics, 22(1), 1-11. doi: 10.1186/s12864-021-08139-3
Ma’rufi, I., Ali, K., Sedemen, I. A., Purwanto, P., & Khoiri, A. (2019). Channa striata (ikan gabus) Extract and the Acceleration of Tuberculosis Treatment: A True Experimental Study. Interdisciplinary Perspectives on Infectious Diseases, 2019, 1-7. doi: 10.1155/2019/8013959
Ma'rufi, I., Ali, K., Jati, S. K., Sukmawati, A., Ardiansyah, K., & Ningtyias, F. W. (2020). Improvement of Nutritional Status among Tuberculosis Patients by Channa striata Supplementation: A True Experimental Study in Indonesia. BioMed Research International, 2020, 7491702. doi: 10.1155/2020/7491702
Marbun, R. I. (2022). Korelasi Keadaan Rumah dengan Kejadian Penyakit TBC Paru. Jurnal Riset Rumpun Ilmu Kedokteran, 1(2), 31-37. doi:10.55606/jurrike.v1i2.410
Massi, M. N., Wahyuni, S., Halik, H., Anita, Yusuf, I., Leong, F. J., … & Phyu, S. (2011). Drug Resistance among Tuberculosis Patients Attending Diagnostic and Treatment Centres in Makassar, Indonesia. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 15(4), 489–495. doi: 10.5588/ijtld.09.0730
Mehta, P., Bothiraja, C., Kadam, S., & Pawar, A. (2018). Potential of Dry Powder Inhalers for Tuberculosis Therapy: Facts, Fidelity and Future. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup3), S791-S806. doi: 10.1080/21691401.2018.1513938
Mitchison, D. A. (1985). The Action of Antituberculosis Drugs in Short-Course Chemotherapy. Tubercle, 66(3), 219-225. doi: 10.1016/0041-3879(85)90040-6
Modongo, C., Sobota, R. S., Kesenogile, B., Ncube, R., Sirugo, G., Williams, S. M., & Zetola, N. M. (2014). Successful MDR-TB Treatment Regimens Including Amikacin are Associated with High Rates of Hearing Loss. BMC Infectious Diseases, 14(1), 1-9. doi: 10.1186/1471-2334-14-542
Molina, P. E., Happel, K. I., Zhang, P., Kolls, J. K., & Nelson, S. (2010). Focus on: Alcohol and the Immune System. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 33(1-2), 97–108.
Mourya, N. M. N., & Mourya, R. M. R. (2017). Multidrug-resistant Tuberculosis (MDR-TB). International Journal of Indigenous Herbs and Drugs, 2(4), 17-23.
Mucugi, N. M. (2017). Molecular Targets and Mechanisms of Action of Pyrazinamide in Mycobacterium tuberculosis (Doctoral dissertation, COPAS, JKUAT).
Musfirah, M., Nurfita, D., & Rangkuti, A. F. (2022). Analysis of Healthy Housing and TB Prevalence in Yogyakarta City. Jurnal Kesehatan Masyarakat, 17(3), 405-414. doi:10.15294/kemas.v17i3.28692
Musser, J. M. (1995). Antimicrobial Agent Resistance in Mycobacteria: Molecular Genetic Insights. Clinical Microbiology Reviews, 8(4), 496-514. doi: 10.1128/CMR.8.4.496
Nawas, A. 2010. Penatalaksanaan TB MDR dan Strategi DOTS Plus. Jurnal Tuberkulosis Indonesia, 7(10), 1-7.
Nijenbandring de Boer, R., Baptista de Oliveira e Souza Filho, J., Cobelens, F., de Paula Ramalho, D., Campino Miranda, P. F., de Logo, K., … & Kritski, A. (2014). Delayed Culture Conversion due to Cigarette Smoking in Active Pulmonary Tuberculosis Patients. Tuberculosis, 94(1), 87–91. doi:10.1016/j.tube.2013.10.005
Nindrea, R. D., Sari, N. P., Harahap, W. A., Haryono, S. J., Kusnanto, H., Dwiprahasto, I., … & Aryandono, T. (2020). Survey Data of Multidrug-resistant Tuberculosis, Tuberculosis Patients Characteristics and Stress Resilience during COVID-19 Pandemic in West Sumatera Province, Indonesia. Data in Brief, 32, 106293. doi: 10.1016/j.dib.2020.106293
Noviyani, A., Nopsopon, T., & Pongpirul, K. (2021). Variation of Tuberculosis Prevalence Across Diagnostic Approaches and Geographical Areas of Indonesia. PLoS ONE, 16(10), e0258809. doi: 10.1371/journal.pone.0258809
Nurhayati-Wolff, H. (2022). Share of the Population Aged 15 Years and Above Who Smoked in Indonesia from 2015 to 2021. Statista.com. Retrieved from https://www.statista.com/statistics/955144/indonesia-smoking-rate/
Nusrath Unissa, A., & Hanna, L. (2017). Molecular Mechanisms of Action, Resistance, Detection to the First-line Anti Tuberculosis Drugs: Rifampicin and Pyrazinamide in the Post Whole Genome Sequencing Era. Tuberculosis, 105, 96-107. doi: 10.1016/j.tube.2017.04.008
O’Connor, C., & Brady, M. F. (2022). Isoniazid - LiverTox - NCBI Bookshelf. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK548754/
Oxlade, O., & Murray, M. (2012). Tuberculosis and Poverty: Why are the Poor at Greater Risk in India? PLoS ONE, 7(11), e47533. doi: 10.1371/journal.pone.0047533
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., … & Raviglione, M. (2016). Tuberculosis. Nature Reviews Disease Primers, 2(1). doi: 10.1038/nrdp.2016.76
Pakadang, S. R., Hilaria, M., Dewi, S. T. R., & Sinala, S. (2021). MIC and MKC Analysis of Herbal Medicine in Indonesia against Mycobacterium tuberculosis. Pharmacognosy Journal, 13(5). doi: 10.5530/pj.2021.13.137
Palomino, J. C., & Martin, A. (2014). Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics, 3(3), 317-340. doi: 10.3390/antibiotics3030317
Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffé, M., & Duncan, K. (2007). Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG. Journal of Bacteriology, 189(10), 3721–3728. doi: 10.1128/JB.01740-06
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012). Tuberculosis and HIV Co-infection. PLoS Pathogens, 8(2), e1002464. doi: 10.1371/journal.ppat.1002464
Phelan, J., Coll, F., McNerney, R., Ascher, D. B., Pires, D. E., Furnham, N., ... & Clark, T. G. (2016). Mycobacterium tuberculosis Whole Genome Sequencing and Protein Structure Modelling Provides Insights into Anti-Tuberculosis Drug Resistance. BMC Medicine, 14(1), 1-13. doi: 10.1186/s12916-016-0575-9
Pitaloka, D. A. E., & Sukandar, E. Y. (2018). Synergistic Study on n-Hexane Extract of Anredera cordifolia (Ten.)v Steenis (binahong) Leaves Combined with Antituberculosis Drugs against Drug-sensitive and Drug-resistant of Mycobacterium tuberculosis. Journal of Applied Pharmaceutical Science, 8(5), 134-138. doi: 10.7324/JAPS.2018.8518
Plinke, C., Cox, H. S., Zarkua, N., Karimovich, H. A., Braker, K., Diel, R., ... & Niemann, S. (2010). embCAB sequence Variation Among Ethambutol-resistant Mycobacterium tuberculosis Isolates without embB 306 Mutation. Journal of Antimicrobial Chemotherapy, 65(7), 1359-1367. doi: 10.1093/jac/dkq120
Pontororing, G. J., Kenangalem, E., Lolong, D. B., Waramori, G., Sandjaja, Tjitra, E., … & Ralph, A. P. (2010). The Burden and Treatment of HIV in Tuberculosis Patients in Papua Province, Indonesia: A Prospective Observational Study. BMC Infectious Diseases, 10, 362. doi: 10.1186/1471-2334-10-362
Pradana, R. F., Nawawi, Y., & Satoto, B. (2018). Chest X-ray Evaluation of Cavitary Lesions among Pulmonary MDR-TB Patients in Kariadi Hospital, Semarang, Indonesia. EJournal Kedokteran Indonesia, 6(2). doi: 10.23886/ejki.6.8468
Putranto, M., Wongkar, M. C., & Sugeng, C. (2018). Profil Pasien Tuberkulosis Paru dengan Penyakit Ginjal Kronik yang Dirawat di RSUP Prof. dr. R. D. Kandou Manado Periode Oktober 2017 – Oktober 2018. E-CliniC, 6(2). doi: 10.35790/ecl.6.2.2018.22113
Ramirez, M. S., & Tolmasky, M. E. (2017). Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules, 22(12), 2267. doi: 10.3390/molecules22122267
Rauf, A., Tahar, N., & Resnia, R. (2019). Aktivitas Penghambatan Fraksi Daun Delima (Punica granatum L.) terhadap Bakteri Mycobacterium tuberculosis. Jurnal Kesehatan, 70-76. doi: 10.24252/kesehatan.v0i0.18044
Rawat, R., Whitty, A., & Tonge, P. J. (2003). The Isoniazid-NAD Adduct is a Slow, Tight-Binding Inhibitor of InhA, the Mycobacterium tuberculosis Enoyl Reductase: Adduct Affinity and Drug Resistance. Proceedings of the National Academy of Sciences, 100(24), 13881-13886. doi: 10.1073/pnas.2235848100
Rehm, J., Baliunas, D., Borges, G. L., Graham, K., Irving, H., Kehoe, T., … & Taylor, B. (2010). The Relation between Different Dimensions of Alcohol Consumption and Burden of Disease: An Overview. Addiction, 105(5), 817–843. doi: 10.1111/j.1360-0443.2010.02899.x
Restrepo, B. I. (2016). Diabetes and Tuberculosis. Microbiology Spectrum, 4(6), 595-606. doi: 10.1128/microbiolspec.TNMI7-0023-2016
Ritonga, I. (2020). Malnutrition Risk Factors In TBC: A Case Study in Medan, Indonesia. Jurnal Aisyah: Jurnal Ilmu Kesehatan, 5(1), 107-111. doi: 10.30604/jika.v5i1.539
Ruiz, P., Rodriguez-Cano, F., Zerolo, F. J., & Casal, M. (2003). Streptomycin as Second-line Chemotherapy for Tuberculosis. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia, 16(2), 188-194.
Russell D. G. (2001). Mycobacterium tuberculosis: Here Today, and Here Tomorrow. Nature Reviews Molecular Cell Biology, 2(8), 569–577. doi: 10.1038/35085034
Ruzangi, J., Iwagami, M., Smeeth, L., Mangtani, P., & Nitsch, D. (2020). The Association between Chronic Kidney Disease and Tuberculosis: A Comparative Cohort Study in England. BMC Nephrology, 21(1), 420. doi: 10.1186/s12882-020-02065-4
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008). Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, And Rifampin. Antimicrobial Agents and Chemotherapy, 52(6), 2027–2034. doi: 10.1128/AAC.01486-07
Safi, H., Lingaraju, S., Amin, A., Kim, S., Jones, M., Holmes, M., … & Alland, D. (2013). Evolution of High-Level Ethambutol-resistant Tuberculosis Through Interacting Mutations in Decaprenylphosphoryl-β-D-arabinose Biosynthetic and Utilization Pathway Genes. Nature Genetics, 45(10), 1190–1197. doi: 10.1038/ng.2743
Safitri, E. A., Siagian, P., Sinaga, B. Y., & Eyanoer, P. C. (2022). Vitamin C Supplementation Improves Pulmonary Tuberculosis Patients' Sputum Conversion during Intensive Phase Category I Treatment in Medan. Respiratory Science, 2(2), 72-77. doi: 10.36497/respirsci.v2i2.30
Sahiratmadja, E., Mega, G. S., Andriyoko, B., & Parwati, I. (2020). Performance of Xpert® MTB/RIF in Detecting Multidrug-Resistance Tuberculosis in West Java, Indonesia. Majalah Kedokteran Bandung, 52(2), 99-106. doi: 10.15395/mkb.v52n2.1966
Santucci, P., Aylan, B., Botella, L., Bernard, E. M., Bussi, C., Pellegrino, E., ... & Gutierrez, M. G. (2022). Visualizing Pyrazinamide Action by Live Single-cell Imaging of Phagosome Acidification and Mycobacterium tuberculosis pH Homeostasis. mBio, 13(2), e00117-22. doi: 10.1101/2021.12.20.473466
Sanz-García, F., Anoz-Carbonell, E., Pérez-Herrán, E., Martín, C., Lucía, A., Rodrigues, L., & Aínsa, J. A. (2019). Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles. Frontiers in Microbiology, 10, 46. doi: 10.3389/fmicb.2019.00046
Saraswati, L. (2014). Prevalens Diabetes Mellitus dan Tuberkulosis Paru. KEMAS: Jurnal Kesehatan Masyarakat, 9(2), 206-2010. doi:10.15294/kemas.v9i2.2850
Sari, D. K., Marpaung, A. P., Siagian, P., & Arrasyid, N. K. (2019). Vitamin A Supplementation in Pulmonary Tuberculosis Patients on Acceleration of Sputum Conversion in Medan City. Open Access Macedonian Journal of Medical Sciences, 7(20), 3505-3508. doi: 10.3889/oamjms.2019.688
Sartini, S., Djide, M. N., Gemini Alam, A. A., & Djide, N. J. N. (2020). In Vitro Antioxidant and Anti-Mycobacterial Activities of Roselle (Hibiscus sabdariffa L.) Calyx Extract against Clinical Isolate of Multidrug Resistant Mycobacterium tuberculosis. Systematic Reviews in Pharmacy, 11(5), 36-39.
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015). Multidrug-resistant Tuberculosis and Extensively Drug-resistant Tuberculosis. Cold Spring Harbor Perspectives in Medicine, 5(9), a017863. doi: 10.1101/cshperspect.a017863
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., … & Zhang, Y. (2011). Pyrazinamide Inhibits Trans-translation in Mycobacterium tuberculosis. Science, 333(6049), 1630-1632. doi: 10.1126/science.1208813
Sianturi, R. (2014). Analisis Faktor yang Berhubungan dengan Kekambuhan TB Paru (Studi Kasus di BKPM Semarang Tahun 2013). Unnes Journal of Public Health, 3(1). doi: 10.15294/ujph.v3i1.3157
Simet, S. M., & Sisson, J. H. (2015). Alcohol's Effects on Lung Health and Immunity. Alcohol Research: Current Reviews, 37(2), 199–208.
Sinaga, B. Y., Siregar, Y., Amin, M., & Sarumpaet, S. (2018). Effect of Smoking and Alcohol Consumption on Pulmonary Tuberculosis among Batak Ethnic Population in Medan, Indonesia. IOP Conference Series: Earth and Environmental Science, 125, 012139. doi:10.1088/1755-1315/125/1/012139
Siregar, R. J., Yusuf, S. F., & Fernaldy, D. (2022). The Relationship between Physical Conditions of the House and the Incidence of Tuberculosis. International Journal of Public Health Excellence (IJPHE), 1(1), 01-05. doi:10.55299/ijphe.v1i1.2
Siroka, A., Law, I., Macinko, J., Floyd, K., Banda, R. P., Hoa, N. B., … & Ponce, N. A. (2016). The Effect of Household Poverty on Tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 20(12), 1603–1608. doi: 10.5588/ijtld.16.0386
Slayden, R. A., & Barry, C. E. (2002). The Role of KasA and KasB in the Biosynthesis of Meromycolic Acids and Isoniazid Resistance in Mycobacterium tuberculosis. Tuberculosis, 82(4-5), 149–160. doi: 10.1054/tube.2002.0333
Soeroto, A. Y., Lestari, B. W., Santoso, P., Chaidir, L., Andriyoko, B., Alisjahbana, B., ... & Hill, P. C. (2019). Evaluation of Xpert MTB-RIF Guided Diagnosis and Treatment of Rifampicin-resistant Tuberculosis in Indonesia: A Retrospective Cohort Study. PLoS ONE, 14(2), e0213017. doi: 10.1371/journal.pone.0213017
Soeroto, A. Y., Pratiwi, C., Santoso, P., & Lestari, B. W. (2021). Factors Affecting Outcome of Longer Regimen Multidrug-resistant Tuberculosis Treatment in West Java Indonesia: A Retrospective Cohort Study. PLoS ONE, 16(2), e0246284. doi: 10.1371/journal.pone.0246284
Sotgiu, G., Centis, R., D'ambrosio, L., & Migliori, G. B. (2015). Tuberculosis Treatment and Drug Regimens. Cold Spring Harbor Perspectives in Medicine, 5(5), a017822. doi: 10.1101/cshperspect.a017822
Sowajassatakul, A., Prammananan, T., Chaiprasert, A., & Phunpruch, S. (2014). Molecular Characterization of Amikacin, Kanamycin and Capreomycin Resistance in M/XDR-TB Strains Isolated in Thailand. BMC Microbiology, 14(1), 1-7. doi: 10.1186/1471-2180-14-165
Sreevatsan, S., Pan, X., Stockbauer, K. E., Williams, D. L., Kreiswirth, B. N., & Musser, J. M. (1996). Characterization of rpsL and rrs Mutations in Streptomycin-resistant Mycobacterium tuberculosis Isolates from Diverse Geographic Localities. Antimicrobial Agents and Chemotherapy, 40(4), 1024-1026. doi: 10.1128/aac.40.4.1024
Stek, C., Allwood, B., Walker, N. F., Wilkinson, R. J., Lynen, L., & Meintjes, G. (2018). The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Frontiers in Microbiology, 9, 2603. doi: 10.3389/fmicb.2018.02603
Sturkenboom, M. G., Simbar, N., Akkerman, O. W., Ghimire, S., Bolhuis, M. S., & Alffenaar, J. W. C. (2018). Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment. Clinical Infectious Diseases, 67(suppl_3), S303-S307. doi: 10.1093/cid/ciy613
Sultana, Z. Z., Hoque, F. U., Beyene, J., Islam, M. A. U., Khan, M. H. R., Ahmed, S., … & Hossain, A. (2021). HIV Infection and Multidrug Resistant Tuberculosis: A Systematic Review and Meta-analysis. BMC Infectious Diseases, 21(51). doi: 10.1186/s12879-020-05749-2
Sun, Q., Li, X., Perez, L. M., Shi, W., Zhang, Y., & Sacchettini, J. C. (2020). The Molecular Basis of Pyrazinamide Activity on Mycobacterium tuberculosis PanD. Nature Communications, 11(1), 1-7. doi: 10.1038/s41467-019-14238-3
Syamsuddin, S., Askar, M., Lestari, I. D., Sahani, W., & Ahmad, H. (2020). The Relationship between Housing Condition and Pulmonary Tuberculosis Disease in Baraya Village, Bontoala Makassar, Indonesia. Indian Journal of Forensic Medicine & Toxicology, 14(4), 3517-3523. doi: 10.37506/ijfmt.v14i4.12172
Tam, K. K., Leung, K. S., Siu, G. K., Chang, K. C., Wong, S. S., Ho, P. L., … & Yam, W. C. (2019). Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. Journal of Clinical Microbiology, 57(8), e00145-19. doi: 10.1128/JCM.00145-19
Tang, R. A., Schiffman, J., Cruz, R. A., & Corsi, G. (2014). Ethambutol: Friend or foe?. Expert Review of Ophthalmology, 9(2), 59-61. doi: 10.1586/17469899.2014.898564
Tania, T., Sudarmono, P., Kusumawati, R. L., Rukmana, A., Pratama, W. A., Regmi, S. M., … & Faksri, K. (2020). Whole-Genome Sequencing Analysis of Multidrug-resistant Mycobacterium tuberculosis from Java, Indonesia. Journal of Medical Microbiology, 69(7), 1013-1019. doi: 10.1099/jmm.0.001221
Taslim, I. (2016). Association of Bacterial Load Degree with Cavity in TB Patient in Persahabatan Hospital. (Bachelor’s thesis). Universitas Indonesia.
Tiberi, S., Utjesanovic, N., Galvin, J., Centis, R., D’Ambrosio, L., van den Boom, M., … & Migliori, G. B. (2022). Drug Resistant TB – Latest Developments in Epidemiology, Diagnostics and Management. International Journal of Infectious Diseases, 124, S20-S25. doi: 10.1016/j.ijid.2022.03.026
Tjekyan, S., Novita, E., & Ismah, Z. (2018). Multidrug-resistant Tuberculosis (MDR-TB): Incidence Rate in Palembang City, South Sumatra, Indonesia. Jurnal Biotek Medisiana Indonesia, 7(1), 19-25. doi: 10.22435/jbmi.v7i1.1566
Tobing, K. L., Nainggolan, O., Rachmawati, F., Manalu, H. S., Sagala, R. D., & Kusrini, I. (2021). The Relationship between Malnutrition and Tuberculosis (TB) at the Age Group More Than 18 Years Old in Indonesia (Analysis of the Basic Health Research 2018). International Journal of Innovation, Creativity and Change, 332-348. doi: 10.53333/ijicc2013/15941
Tseng, S. T., Tai, C. H., Li, C. R., Lin, C. F., & Shi, Z. Y. (2015). The Mutations of katG and inhA Genes of Isoniazid-resistant Mycobacterium tuberculosis Isolates in Taiwan. Journal of Microbiology, Immunology and Infection, 48(3), 249-255. doi: 10.1016/j.jmii.2013.08.018
Umar, M. I., Asmawi, M. Z., Sadikun, A., Majid, A. M. S. A., Al-Suede, F. S. R., Hassan, L. E. A., ... & Ahamed, M. B. K. (2014). Ethyl-p-methoxycinnamate Isolated from Kaempferia galanga Inhibits Inflammation by Suppressing Interleukin-1, Tumor Necrosis Factor-α, and Angiogenesis by Blocking Endothelial Functions. Clinics, 69, 134-144. doi: 10.6061/clinics/2014(02)10
Umar, F. F., Husain, D. R., Hatta, M. M., Natzir, R. R., Sjahril, R. S., Dwiyanti, R. R., Junita, A. R., & Primaguna, M. R. (2020). Molecular Characterisation of Mutations Associated with Resistance to First- and Second-line Drugs among Indonesian Patients with Tuberculosis. Journal of Taibah University Medical Sciences, 15(1), 54-58. doi: 10.1016/j.jtumed.2019.12.003
Urbanowski, M. E., Ordonez, A. A., Ruiz-Bedoya, C. A., Jain, S. K., & Bishai, W. R. (2020). Cavitary Tuberculosis: The Gateway of Disease Transmission. The Lancet Infectious Diseases, 20(6), e117–e128. doi: 10.1016/S1473-3099(20)30148-1
Vera, Y., Sinaga, B. Y., Ardinata, D., & Siregar, Y. (2018). The Effect of pncA Gene Mutation of Mycobacterium tuberculosis to Rransaminase and Uric Acid Serum in MDR-TB Patients. Jurnal Respirologi Indonesia, 38(3), 150-157. doi: 10.36497/jri.v38i3.4
Wahyudi, A. S., Raufuddin, & Suarilah, I. (2018). The Relationship between Healthy Housing Conditions and Pulmonary Tuberculosis. Proceedings of the 9th International Nursing Conference. doi:10.5220/0008330506570663
Wang, F., Shen, H., Guan, M., Wang, Y., Feng, Y., Weng, X., ... & Zhang, W. (2011). High-resolution Melting Facilitates Mutation Screening of rpsL Gene Associated with Streptomycin Resistance in Mycobacterium tuberculosis. Microbiological Research, 166(2), 121-128. doi: 10.1016/j.micres.2010.02.001
Waters, M., & Tadi, P. (2020). Streptomycin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555886/
Wei, M., Zhao, Y., Qian, Z., Yang, B., Xi, J., Wei, J., & Tang, B. (2020). Pneumonia Caused by Mycobacterium tuberculosis. Microbes and Infection, 22(6-7), 278-284. doi: 10.1016/j.micinf.2020.05.020
Widiastuti, E. N., Subronto, Y. W., & Promono, D. (2017). Determinan Kejadian Multi-drug Resistant Tuberculosis di RSUP dr. Sardjito. Berita Kedokteran Masyarakat, 33(7), 325. doi:10.22146/bkm.18290
Windiyaningsih, C., & Badaruddin, H. (2021). Factors Influenced of Drug-Resistant Tuberculosis and Non-Drug-resistant Tuberculosis Patients in Pulmonary Hospital dr. M. Goenawan Partowidigdo, Bogor District. Tarumanagara Medical Journal, 3(2), 238-248. doi:10.24912/tmj.v4i1.13714
Wiwing, V., Widysanto, A., & Lugito, N. P. H. (2015). Mycobacterium tuberculosis Resistance Pattern Against First-line Drugs in Patients from Urban Area. International Journal of Mycobacteriology, 4(4), 302-305. doi: 10.1016/j.ijmyco.2015.08.002
World Health Organization. (2019). Global Tuberculosis Report 2019. Geneva: WHO.
World Health Organization. (2021). Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association with Drug Resistance. Geneva: WHO
World Health Organization. (2022). Global Tuberculosis Report 2022. Geneva: WHO.
Xi, Y., Zhang, W., Qiao, R. J., & Tang, J. (2022). Risk Factors for Multidrug-resistant Tuberculosis: A Worldwide Systematic Review and Meta-analysis. PLoS ONE, 17(6), e2070003. doi: 10.1371/journal.pone.0270003
Yao, F., Huang, Y., Wang, Y., & He, X. (2018). Anti-inflammatory Diarylheptanoids and Phenolics from the Rhizomes of Kencur (Kaempferia galanga L.). Industrial Crops and Products, 125, 454-461. doi: 10.1016/j.indcrop.2018.09.026
Zhang, Y., Shi, W., Zhang, W., & Mitchison, D. (2014). Mechanisms of Pyrazinamide Action and Resistance. Microbiology Spectrum, 2(4), 2-4. doi: 10.1128/microbiolspec.MGM2-0023-2013
Zhang, Q., An, X., Liu, H., Wang, S., Xiao, T., & Liu, H. (2019). Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin due to RNA Polymerase H451D/Y/R Mutations from Computational Perspective. Frontiers in Chemistry, 7, 819. doi: 10.3389/fchem.2019.00819
Zhang, Z., Wang, W., Wang, Y., Xue, Z., Li, S., & Pang, Y. (2022). Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China. Infection and Drug Resistance, 15, 2287. doi: 10.2147/idr.s357887
Zaunbrecher, M. A., Sikes Jr, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009). Overexpression of the Chromosomally Encoded Aminoglycoside Acetyltransferase Eis Confers Kanamycin Resistance in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 106(47), 20004-20009. doi: 10.1073/pnas.0907925106
Zhu, C., Liu, Y., Hu, L., Yang, M., & He, Z. G. (2018). Molecular Mechanism of the Synergistic Activity of Ethambutol and Isoniazid against Mycobacterium tuberculosis. Journal of Biological Chemistry, 293(43), 16741-16750. doi: 10.1074/jbc.RA118.002693
Published
2023-03-24
How to Cite
Putri, O., Salim, M., Gunawan, A., Devin, D., Amaris, E., Alexander, D., Kevin, G., & Febriana, G. (2023). Drug-Resistant Pulmonary Tuberculosis. Indonesian Journal of Life Sciences, 5(01), 10-40. https://doi.org/https://doi.org/10.54250/ijls.v5i01.172
Issue
Section
Life Science for Health and Wellbeing
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles published in Indonesian Journal Life of Sciences are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and Indonesian Journal Life of Sciences, link to the license, indicate if changes were made, and redistribute any derivative work under the same license. Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to Indonesian Journal Life of Sciences to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals. By publishing in Indonesian Journal Life of Sciences, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.
